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The existence of microbe free animals or plants in nature is virtually impossible as they and plants have a certain
degree of symbiotic association with microbes. This symbiotic association leads to the formation of holobiont
(host and its symbionts). This mutual coexistence is not merely at the physical or chemical level but also at the
genetic level leading to the emergence of the concept of hologenome (gene pool of host and its associated
symbionts). The abundance of symbionts with the associated gene diversity contributes to the fitness of the
holobiont under varying environmental conditions. The hologenome theory of evolution considers the dynamic
holobiont as a single unit for natural selection and provides a more accommodating view of evolution blending
Darwinism and Lamarkism. Additionally, holobionts are providing scientific basis to our understanding of the
growing importance of probiotics in human health and in disease management.
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During the course of evolution, multicellular living
forms emerged from unicellular life; the latter not only
predominates the multicellular life quantitatively but
also has a close association with it. There are many types
of associations that have developed during evolution
ranging from mutualism to parasitism. Such associations
always affect the life of multicellular hosts in the short
term from birth to death, with implications on their sur-
vival in the environment, and in the long term as a
phenotypic unit for natural selection. Such relationships
lead to formation of a holobiont [1,2] that includes host
and its associated microbiota or symbionts (Figure 1).
Although the word “Holobiont” was coined by Lynn
Margulis in 1991, to signify symbiosis between individual
organisms or the bionts [1], the concept was highlighted
in 2002 and later during the study of corals, and their
associated symbionts, as coral holobionts [2]. Symbionts
can be divided into two categories, endosymbionts and
exosymbionts which refer to symbionts living inside or
outside of the host cells, respectively. Such associations* Correspondence: seyedhasnain@gmail.com
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reproduction in any medium, provided the orresult in a hologenome comprising of genetic informa-
tion of both host and the associated microbiota [3].
Hologenome includes the static genome of the host
alongwith dynamic genome of the symbiota. The
dynamism of symbiota’s genome provides the compe-
tence to holobiont to adapt and survive in different
environmental conditions. The hologenome theory of
evolution considers the alliance of holobiont with its
hologenome as a selection unit for evolution to act upon
[3]. Further hologenome theory of evolution can be helpful
in comprehending the emerging constructive role of
probiotics in human health.
Hologenome theory and evolution
Natural selection acts at multi-levels i.e. at the genetic
level, individual level or community level. Recent reports
suggest that natural selection also operates at the level of
holobiont. The hologenome theory of evolution, proposed
by Zilber-Rosenberg and Rosenberg [4], is based on the
following assumptions:
1) There is abundance and diversity in microbial
population housed by all animals and plants.
2) The microbial symbionts influence their holobiont
fitness and vice versa.td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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Figure 1 The concept of hologenome. Hologenome consist of genome of holobiont which includes host and its associated symbiota having a
mutual beneficial relationship. Symbiota not only protects the host from pathogens but also decreases immune disorders by immunomodulation.
While host provides shelter and nutrients to the symbiota, symbiota in turn also improve various body functions such as digestion to provide
essential nutrients to the host.
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genome result in variations in the hologenome.
4) Transmission of hologemone variations can occur
with fidelity.
This theory came into existence based on observation
on Vibrio shiloi infection in corals. With time corals
became resistant to infection despite the fact that they
lack an advanced immune system [5]. In case of coral
holobionts, microbiota help the corals to adapt to chan-
ging environmental conditions [6]. For example in the
bleaching process, when due to increase in sea water
temperature, corals start to lose their symbiotic zoo-
xanthallae. These symbionts act as a source of carbon
and molecular oxygen. According to adaptive hypothesis
of coral bleaching [7], the expulsion of algae paves way
for the infection of temperature resistant zooxanthallae,
which led to a more favorable symbiosis. This led to the
presentation of coral probiotic hypothesis [8]. Thus, the
existence of dynamic relationship between symbionts
and corals under different environmental conditions led
to the selection of most advantageous coral holobiont in
the background of prevailing conditions.
Abundance and diversity in microbial population housed
by all animals and plants
Microbes are the most abundant organisms on this
earth. Surface of animals and plants is always in physical
contact with water, soil or air which in turn contains mi-
crobes as a function of a unit area. Previously known
culture dependent isolation techniques for these host as-
sociated bacteria underestimated their diversity. Recently
developed culture independent molecular biology tech-
niques like 16S rRNA sequence analysis and high
throughput sequencing have suggested a fresh estimate
of the number of microbial species associated with the
hosts. For example, an average human body, made up of10 trillion cells, is now estimated to harbor 100 trillion
cells representing distinct microbial species in the gut
alone. According to these figures, the number of unique
bacterial genes alone in the human gut becomes ~150
times more than the number of human genes [9]. Other
human body systems like skin, urogenital system and
respiratory system also harbors microbes with a great
abundance and diversity. The potential for variations in
hologenome is thus increased as a function of the number
of unique symbiont genomes.
The microbial symbionts influence their holobiont fitness
and vice versa
Genetic diversity of microbiota can help the holobiont
to increase the efficiency of adaptation to the variations
in environment. While the host provides a sheltered and
nutrient rich environment for survival and growth of
microbiota, in extreme cases like in absolute mutualism,
survival of both host and the symbiont is completely
dependent on each other. Extreme symbionts such as
mitochondria and chloroplasts can directly influence the
survival of their host as mutations affecting their func-
tion lead to various diseases in the host. Symbiota also
help in adaptation in varying environmental conditions.
For example in bovine rumen symbiosis, microbiota help
the host to get energy and nutrients from complex plant
material by providing various bacterial enzymes that are
otherwise not synthesized by the host. In case of human
gut holobiont, research on germ free animals indicated
that the normal microbiota help in development and
functioning of normal immune system [10-12], angio-
genesis [13], regulation of fat accumulation [14] along
with food breakdown and biotransformation. Alteration
in metabolism modulated by progressive changes in
microbiota composition in humans during the course of
pregnancy has been found to be supportive for the
growth of fetus [15]. Recently it was found that
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more prone to obesity as they did not acquire the nor-
mal microbiota which would have been acquired during
normal vaginal delivery [16].
Normal microbiota also competes for space with the
pathogenic microbes to provide protection against infec-
tious disease in the host. For example in human, microbiota
on mucosal surface resist infection by mucosal pathogens
through antibacterial release and binding to adhesion sites
[17]. Interestingly, it has been shown that immune response
to symbiota via IgM differs from its reaction to pathogens
[18]. It was further observed that human skin symbiota
composition affects the attractiveness to mosquitoes by
producing different human odour volatiles as their metabo-
lites [19]. This may alter their susceptibility to malaria as
malarial parasites are transmitted by these mosquitoes.
During the course of evolution, symbiosis between
reteroviruses and primitive egg laying mammals is believed
to have led to the development of placental mammals
through genetic integration of reteroviral genes in the host
[20]. Other examples include those where the coral
symbiota help in nitrogen fixation [21], nutrients assimila-
tion [22] and prevention of infections by antibiotic produc-
tion [23-25].
Termites with their symbionts in the gut represent exam-
ples where they not only help in nutrient assimilation but
also affect the social behavior [26]. This is evident from
study of diet induced mating preference in Drosophila due
to symbionts [27] that alter the levels of cuticular hydrocar-
bon sex pheromones to induce a mating preference.
Alongwith geographic separation and slower changes in
host genomes, such mating preference will lead to the evo-
lution of species [28,29]. In some rare cases, like in coffee
beetle, a gene important for beetle survival has been
found to have bacterial origin. This gene might have
been acquired during evolution by the beetle from the
bacteria through nonsexual horizontal gene transfer [30].
In case of pea aphid (Acyrthosiphon pisum), a symbiont
bacterial species (Hamiltonella defensa) acts as an anti-
parasite defender by killing the developing parasitic wasp
larvae, thus enhancing the survival of the host [31].
Symbionts have also been found to play important
role in organogenesis in host. For example, the sym-
biont Vibrio fischeri helps in development of squid light
organ of Hawaiian bobtail squid Euprymna scolopes
[32,33]. Both can grow independently but in the absence of
symbiont there will be no light organ formation. This
observation points to the existence of interspecies signaling.
Modifications in the host genome or microbiota genome
result in variations in the hologenome
Inequality of traits, termed as variations, synthesize the
basic substrate for evolution. Variations in host genome can
be acquired during sexual reproduction, recombination,rearrangement of chromosomes, and due to genetic and
epigenetic mutations. In haploid bacteria recombination
occurs through transduction, DNA transformation and
conjugation. In symbionts, besides recombination and the
methods mentioned above, there are three other processes
by which variations can be acquired. These include: micro-
bial proliferation, acquisition of exotic strains, and hori-
zontal gene transfer. Unique to the hologenome theory of
evolution, these processes can occur rapidly depending on
environmental need and are important factors in the adap-
tation and evolution of animals and plants [4].
Microbial proliferation
The proliferation of microbes is the most accelerated
mode of generating variation in holobionts. It includes
changes in the relative abundance of the various types of
associated symbionts that can occur as a consequence of
changing environmental factors. Relative increase in the
number of a specific microbe is analogous to gene amplifi-
cation. Considering the abundance and diversity of micro-
biota, this process becomes a potent mechanism for
adaptation in changing environment. Diet induced change
in gut microbiota is the most studied example [34,35].
Acquisition of exotic strains
During the life time, animals and plants come in contact
with billions of microbes. There are chances when a
particular bacterium finds an appropriate niche for
establishment in the host leading to symbiosis. Certain
environmental conditions can render a new symbiont
more abundant, resulting in alteration in the holobionts
phenotype. Unlike microbial amplification, acquiring
new symbionts from the environment can result in im-
port of entirely novel genes into the hologenome. For
example, the administration of probiotics restores the
lost beneficial bacterial strains during antibiotic therapy
in various infectious and noninfectious gastrointestinal
disorders [36]. In case of whitefly, the symbiont Rickettsia
is initially acquired through feeding on the infected plant
resulting in a plant mediated horizontal transmission in
the insect [37].
Horizontal gene transfer
Horizontal gene transfer from exotic to resident microbe
is an additional robust method for generating variability in
symbionts. An example is the transfer of porphyranases,
agarases and associated protein coding genes from a
marine member of the bacteroidetes to the human gut
bacterium Bacteroide splebeius in the Japanese population
[38]. This process is mostly mediated by mobile genetic
elements like transposons, plasmids, bacteriophages and
genomic islands. Interestingly, genomic islands are present
in pathogens as pathogenicity islands [39], as well as in
beneficial symbionts as symbiosis islands [40] and are
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Genetic information exchange between pathogens and
symbionts may also be brought by horizontal gene
transfer [41,42].
Transmission of hologemone variations can occur with
fidelity
Trans-generational transmission of host genetic informa-
tion in an error proof manner has been well characterized.
In recent years, similar type of information for symbionts
has started to emerge [43]. There are two different types of
modes of transmission: horizontal (from environment) and
vertical (from parents/mother). However a mixture of both
modes is also prevalent in nature. There are several exam-
ples of direct mode of transmission or trans-ovarian mode.
Cytoplasmic inheritance of mitochondria and chloroplast
(presumed as extreme symbionts) occurs when a eukaryotic
cell divides. In the aphid–Buchnera symbiosis, bacteria are
intracellularly present in specialized host cells called
bacteriocytes and are transferred to next generation by
trans-ovarian transmission [44].
Other than trans-ovarian transmission, there is trans-
mission through direct contact in several cases. For ex-
ample, in humans, initial symbiont population is acquired
during passage through birth canal and later by close
physical contact with family. It was observed that micro-
biota similarity in a human population was more within
family than between families in a particular area [45,46].
Role of microbiota in human health: importance
of probiotics
According to World Health Organization/Food and













Figure 2 Importance of gut probiotics in human health. The probiotics
composition, metabolism and immunity. All these functions of probiotics a
infections and disorders alongwith strengthening the mucosal immunity. Prob
metabolism of lactose and lowers the level of cholesterol. Probiotics enhance
and inflammation by immunomodulation.as live microbial species which when ingested in suffi-
cient amount render beneficial effects on human and
animal health [47]. The gut symbiota (probiotics) play
an important role in maintaining normal microbial com-
position, metabolism and immunity of gut (Figure 2). All
these functions of probiotics are correlated to each
other. Probiotics not only provide protection against
pathogens at local or mucosal surfaces but also play an
important role in the development of systemic immunity
through immunomodulation. Local protection is pro-
vided by various means. Probiotics compete for binding
to adhesion sites at host cell surface that are also
required by a pathogen. Further, probiotics can release
many types of antibacterial which can either kill or in-
hibit the growth of pathogens. Change in the milieu i.e.
alteration in pH through secretion is another way to
inhibit the growth of pathogens by probiotics. Binding of
probiotics to host cell receptors can induce the host cells
to secrete various anti-inflammatory compounds which
results in amelioration of inflammatory response/tissue
damage [48]. Probiotics can also bind to bacterial toxins
resulting in toxin neutralization [49]. Similar type of protec-
tion can be provided by symbiota associated with other or-
gans i.e. oral cavity, skin, respiratory tract and urogenital
tract (Figure 3). Probiotics also improve immunity through
immunomodulation. In immunomodulation, gut probiotics
interact with antigen presenting cells i.e. macrophages and
dendritic cells. Upon interaction with probiotics these cells
secrete certain cytokines which regulate the function of cer-
tain regulatory T cells, resulting in immunomodulation
[50]. This immunomodulation (Figure 4) results in an
effective immune system by decreasing the susceptibility
to various inflammations and allergies through varioustics
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Figure 3 Probiotics impact mucosal/surface immunity. Probiotics can provide local or mucosal immunity and protection from many
pathogens in a diversified manner. They can affect the adhesion of different pathogens to host cell surface by competitive exclusion. The binding
of probiotics can induce the host cells to secrete anti-inflammatory cytokines which will decrease the inflammation at the tissue surface.
Probiotics can also secrete antimicrobials to inhibit the growth of pathogens. The metabolites of probiotics like lactic acid from lactobacillus
bacterium can result in alteration of pH in lumen or at surface, which can ultimately inhibit the growth of certain pH sensitive pathogens.
Probiotics can also bind to toxin released by pathogens resulting in neutralization of the toxins. Similar types of protection can be provided by
symbiota associated with other organs i.e. oral cavity, skin, respiratory tract and urogenital tract.
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gut-skin axis [51-54].
Probiotics have already been exploited either to treat
or to prevent a number of gut health disorders such as
irritating bowel syndrome [55], hypersensitivity including
food allergies [56], hypercholesterolemia [57], gastritis, gut
infection [58], parasitic infestation [59] and even certain
forms of cancers including colorectal cancer [60]. Micro-
biota as probiotics also hold potential for use in oral health
to prevent and treat the oral infections, dental plaque-
related diseases, periodontal diseases and halitosis [61].
Intestinal microbiota also modulate the immune system
(Figure 4), thus decreasing the chances of getting aller-
gies of skin like eczema and of respiratory system like
asthma [62]. Urogenital microbiota also help to reduce
the urogenital infection in woman by preventing patho-
gen adhesion and secretion of antibacterial compounds
[63]. Results from animal studies have shown the im-
portant role of microbiota in formation of microbiome-gut-brain axis, which can affect brain and behavior [64].
Probiotics can also modulate brain functions including
stress response in humans [65]. Symbiota associated
with other organs also hold similar potential to treat or
prevent human health disorders linked to those organs.
Given the important role of probiotics on the host meta-
bolism and function, one can argue whether it is appropri-
ate to assign definitive functions to host genes in the
absence of knowledge about cross-talks between host and
the symbiont genes.
Genetically engineered probiotics: potential of
recombinant probiotics
Recombinant DNA technology makes it possible to
increase the prophylactic and therapeutic efficacy of
existing probiotic strains as well as to create completely
new probiotic strains. Through improvement of stress
tolerance during pharmaceutical formulation and in

































Figure 4 Role of probiotics in systemic immunity. Probiotics can improve the generalized immunity by immunomodulation. In
immunomodulation, gut probiotics interact with antigen presenting cells i.e. macrophages and dendritic cells (DC). These APC then affect the
T cells population (mainly regulatory cells) to induce systemic immunomodulation. This immunomodulation through gut-brain axis, gut-lung axis
and gut-brain-skin/gut-skin axis improves the function of brain, lungs and skin respectively, by reducing the susceptibility to various stresses
and allergies.
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This task can be accomplished with the help of
pathobiotechnology, in which pathogenic bacteria are
exploited for their better stress response, host inter-
action and survival within host for constructive use in
biotechnology [66]. For example, a better stress toler-
ance of the bacteriocin producing probiotic bacterium
Lactobacillus salivarius UCC118 was observed when a
betaine uptake system gene involved in osmotic stress
tolerance was cloned from Listeria monocytogenes into
the probiotic strain [67]. Genetically modified probiotics
can also be used in replacement therapies in which a
pathogenic microbe is replaced by its harmless and
robust competitor in the same ecological niche. For ex-
ample, the cariogenic wild type bacterium Streptococcus
mutans was replaced by a mutant lacking lactic acid
producing gene responsible for dental caries [68].
Genetic engineering of probiotics has also led to the
emergence of concept of designer probiotics. These
probiotics are genetically engineered to express the
mimics of host cell receptors for pathogenic microbes
on surface [49]. Such probiotics can be used in effective
toxin sequestration, neutralizing antibody production,
and detoxification [69]. Recently scientists have also
started to exploit the role of probiotics as vaccine,
immune cell mediators and delivery systems. The recent
report of therapeutic and prophylactic molecules deliv-
ery by lactic acid bacteria [70] promises to render these
modified probiotics for use in anti-inflammatory, anti-
tumor and anti-viral therapies.
Genetically modified symbiota in other species can
also have medical applications. For example the recent
engineering of a mosquito symbiotic bacteria to secrete
anti-Plasmodium effector proteins making them resis-
tant to malarial infection [71] represent a new strategy
for intervention against malaria. Genetically engineeredsymbiota holds the potential to enhance the production
performance of various animals and plants associated
with human society.
Conclusion and epilogue
The hologemone concept evaluated the combination of
host and symbiota genomes as a single unit for natural
selection by environmental forces leading to the evolu-
tion of holobiont. Microbial diversity has been found to
affect fitness in terms of adaptation and survival of the
host in various environmental conditions. Change in
coral associated flora during bleaching process, diet
induced changes in gut microbiota population diversity,
and altered mating preference in Drosophila and Vibrio
associated organ morphogenesis in squid are some
examples. Early evolutionary theories fail to consider the
role of microbial diversity in evolution of animal or plant
host. These evolutionary theories were mainly influenced
by Darwin, Lamark, Weismann and Mendel. Darwin’s
Natural selection selects only those phenotypes which
are beneficial to host in terms of struggle for existence
and survival of fittest. Lamark’s use or disuse of charac-
teristics has an effect on their long term development
and traits acquired during lifetime can be transferred to
the next generation. Weismaan proposed that germ cell
inheritance occurs by germ cells which are not affected
by acquired traits of somatic cells. Mendelian genetics
considered random mutations as the source for variations
leading to evolutions. All these theories were unable to
explain all types of inheritance observed in nature. Thus
inheritance of DNA sequence independent changes in
terms of epigenetic inheritance lead to emergence of neo-
Lamarkism which was able to cross Weismaan barrier of
germ cell inheritance of acquired traits. The hologenome
theory of evolution signifies the amalgam of Darwinism
and Lamarckism [72]. It considered the highly dynamic
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leading to evolution as well as inheritance of acquired
characters in the form of change in symbiotic population
modulated by environmental forces.
Darwin’s four postulates hold true for holobiont. 1)
Each holobiont differs from the other holobionts in terms
of diversity and abundance of symbionts associated with
host. 2) The diversity and abundance are directly related
to the potential for variation in hologenome and transmis-
sion of hologemone variations can occur with fidelity. 3)
The microbial symbionts affect their holobiont fitness,
which can depend upon diversity and relative abundance
of symbionts. This fitness can affect the survival and
reproduction in case of holobiont. 4) Holobionts with
high potential of fitness are most likely to survive for
reproduction.
Due to dynamic nature of holobiont, there can be
changes in relative diversity of symbionts as directed by
the environmental forces. The use and disuse of a particu-
lar character in terms of symbiont phenotype over time
justify Lamark’s first principle of use and disuse. Lamark’s
second principle of inheritance of acquired characters also
holds true in case of holobiont as variations in holobionts
can be transmitted to next generation with fidelity.
Hologenome theory of evolution helps better under-
stand fitness potential of the holobiont. It also provides a
tool to alter the hologenome to increase the fitness by al-
tering the dynamic symbiont population. As it is difficult
to alter the host genome, an alteration of the hologenome
through symbiont’s genome variations can render better
host survival under harsh conditions.
Concepts of pathobiotechnology, designer probiotics
and replacement therapy have highlighted the potential
of modified probiotics for human health. The four as-
sumptions of the hologenome theory of evolution [4] will
not only help evaluate the constructive role of the natural
probiotics in human health but also predict the outcome
of interactions of genetically modified probiotics with the
human holobiont in the long term. Generation of modified
probiotics also requires an efficient biological containment
system to prevent the potential spread of the modified
genetic trait across the natural symbiota.
Thus a deep understanding of hologenome theory will
greatly aid in harnessing the therapeutic potential of
microbiota in human health from the clinical perspective.
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